Rapid risk assessment outlines actions to reduce the spread of the mcr-1 gene

In a rapid risk assessment, researchers outline a number of actions that need to be considered to reduce identified risks of mcr-1 spread. These include improved laboratory methods for colistin resistance testing and mcr-1 detection, improved surveillance, options for appropriate clinical management, and actions to prevent transmission in healthcare settings as well as in the community.